|
|
|
|
The H-loop in the Second Nucleotide-binding Domain of the Cystic Fibrosis Transmembrane Conductance Regulator is Required for Efficient Chloride Channel Closing
_ The H-loop in the Second Nucleotide-binding Domain of the Cystic Fibrosis Transmembrane Conductance Regulator is Required for Efficient Chloride Channel Closing.
|
|
|
Life Sciences: New findings from Korea University describe advances in life sciences
Today's Medical & Research News Life Sciences New findings from Korea University describe advances in life sciences March 10th, 2010 Printer-Friendly Version City:Seoul Country:South Korea Life Sciences Hydroxylase Enzymes Sodium Chloride...
|
|
|
New and Generic Drug Approvals
Visit Drugs@FDA to search Drug Approval Reports by Month.March 9, 2010 Betaxon (levobetaxolol hydrochloride) Ophthalmic Suspension, Alcon Research, Ltd., Labeling Revision ChloraPrep One-Step (chlorhexidine gluconate and isopropyl alcohol) Sponge, Enturia...
|
|
|
New and Generic Drug Approvals
Visit Drugs@FDA to search Drug Approval Reports by Month.Betaxon (levobetaxolol hydrochloride) Ophthalmic Suspension, Alcon Research, Ltd., Labeling Revision ChloraPrep One-Step (chlorhexidine gluconate and isopropyl alcohol) Sponge, Enturia Inc., Labeling...
|
|
|
UPS Systems Safeguard Hospital Data Center
/strong> -- Grand River Hospital and Medical Center is the main campus of Grand River Hospital District, a network of clinics and health providers that serve more than 27,000 people throughout Western Colorado.The 62,730 square foot campus houses...
|
|
|
NASDAQ Halts Trading Today in Salix Pharmaceuticals Stock
Salix Pharmaceuticals, Ltd.(NASDAQ:SLXP) today announced that NASDAQ has halted trading of the Companys common stock this morning. The Gastrointestinal Drugs Advisory Committee of the FDA is meeting today to discuss the efficacy and safety of the New Drug...
|
|
|
NASDAQ halts trading of Salix Pharmaceuticals stock, FDA Committee to discuss XIFAXAN NDA
Salix Pharmaceuticals, Ltd.(NASDAQ:SLXP) today announced that NASDAQ has halted trading of the Companys common stock this morning. The Gastrointestinal Drugs Advisory Committee of the FDA is meeting today to discuss the efficacy and safety of the New Drug...
|
|
|
NASDAQ Halts Trading Today in Salix Pharmaceuticals Stock
RALEIGH, N.C.-- (BUSINESS WIRE) -- (NASDAQ:SLXP) today announced that NASDAQ has halted trading of the Companys common stock this morning.The Gastrointestinal Drugs Advisory Committee of the FDA is meeting today to discuss the efficacy and safety of the New...
|
|
|
NASDAQ Halts Trading Today in Salix Pharmaceuticals Stock
RALEIGH, N.C.--(BUSINESS WIRE)--Salix Pharmaceuticals, Ltd.(NASDAQ: SLXP) today announced that NASDAQ has halted trading of the Company?s common stock this morning. The Gastrointestinal Drugs Advisory Committee of the FDA is meeting today to discuss the...
|
|
|
NASDAQ Halts Trading Today in Salix Pharmaceuticals Stock
BusinessWire - Salix Pharmaceuticals, Ltd.(NASDAQ:SLXP) today announced that NASDAQ has halted trading of the Company's common stock this morning. The Gastrointestinal Drugs Advisory Committee of the FDA is meeting today to discuss the efficacy and safety...
|
|
|
NASDAQ Halts Trading Today in Salix Pharmaceuticals Stock
Companies mentioned in this article: Salix Pharmaceuticals, Ltd.RALEIGH, N.C. -- (BUSINESS WIRE) -- Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that NASDAQ has halted trading of the Companys common stock this morning. The Gastrointestinal...
|
|
|
NASDAQ Halts Trading Today in Salix Pharmaceuticals Stock
FDA Advisory Committee Reviewing XIFAXAN (rifaximin) Tablets, 550 mg NDA Buzz up!Companies: Related Quotes {"s" : "slxp","k" : "c10,l10,p20,t10","o" : "","j" : ""} RALEIGH, N.C.--(BUSINESS WIRE)--Salix Pharmaceuticals, Ltd! (NASDAQ:SLXP - News) today...
|
|
|
NASDAQ Halts Trading Today in Salix Pharmaceuticals Stock
RALEIGH, N.C.- (Business Wire) Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that NASDAQ has halted trading of the Companys common stock this morning. The Gastrointestinal Drugs Advisory Committee of the FDA is meeting today to discuss the...
|
|
|
NASDAQ Halts Trading Today in Salix Pharmaceuticals Stock
RALEIGH, N.C.- (BUSINESS WIRE) - Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that NASDAQ has halted trading of the Company's common stock this morning. The Gastrointestinal Drugs Advisory Committee of the FDA is meeting today to discuss the...
|
|
|
NASDAQ Halts Trading Today in Salix Pharmaceuticals Stock
Salix Pharmaceuticals Ltd (SLXP) Stock Quote, Chart, News, Add to Watchlist Salix Pharmaceuticals, Ltd.SLXP today announced that NASDAQ has halted trading of the Companys common stock this morning. The Gastrointestinal Drugs Advisory Committee of the FDA...
|
|
|
NASDAQ Halts Trading Today in Salix Pharmaceuticals Stock
FDA Advisory Committee Reviewing XIFAXAN (rifaximin) Tablets, 550 mg NDA Salix Pharmaceuticals, Ltd.(NASDAQ:SLXP) today announced that NASDAQ has halted trading of the Company's common stock this morning. The Gastrointestinal Drugs Advisory Committee of...
|
|
|
Salix Pharmaceuticals Announces 4Q2009 and FY2009 Financial Results Conference Call and Webcast
- Salix Pharmaceuticals, Ltd.(NASDAQ:SLXP) today announced that the Company will report fourth quarter 2009 and full year 2009 financial results following the close of the U.S. financial markets on Tuesday, March 9, 2010. The Company will host a...
|
|
|
Salix Pharmaceuticals to Present at Three Investment Conferences in March
Salix Pharmaceuticals, Ltd.(NASDAQ: SLXP) today announced that the Company will present at three health care investment conferences during March 2010. Information on these conferences is provided below: RBC Capital Markets Healthcare Conference New York, N...
|
|
|
Salix Pharmaceuticals to Present at Three Investment Conferences in March
- Salix Pharmaceuticals, Ltd.(NASDAQ: SLXP) today announced that the Company will present at three health care investment conferences during March 2010. Information on these conferences is provided below: Interested parties can access a live audio web cast...
|
|
|
Salix Pharmaceuticals Announces4Q2009 and FY2009 Financial ResultsConference Call and Webcast
RALEIGH, N.C.--(BUSINESS WIRE)--Salix Pharmaceuticals, Ltd.(NASDAQ: SLXP) today announced that the Company will report fourth quarter 2009 and full year 2009 financial results following the close of the U.S. financial markets on Tuesday, March 9, 2010.
|
|
|
Salix Pharmaceuticals Announces 4Q2009 and FY2009 Financial Results Conference Call and Webcast
RALEIGH, N.C.-- (BUSINESS WIRE) -- (NASDAQ:SLXP) today announced that the Company will report fourth quarter 2009 and full year 2009 financial results following the close of the U.S.financial markets on Tuesday, March 9, 2010. The Company will host a...
|
|
|
Salix Pharmaceuticals to Present at Three Investment Conferences in March
RALEIGH, N.C.-- (BUSINESS WIRE) -- (NASDAQ: SLXP) today announced that the Company will present at three health care investment conferences during March 2010.Information on these conferences is provided below: RBC Capital Markets Healthcare Conference New...
|
|
|
Salix Pharmaceuticals Announces 4Q2009 and FY2009 Financial Results Conference Call and Webcast
(BUSINESS WIRE) ----Salix Pharmaceuticals, Ltd.(NASDAQ:SLXP) today announced that the Company will report fourth quarter 2009 and full year 2009 financial results following the close of the U.S. financial markets on Tuesday, March 9, 2010. The Company...
|
|
|
Salix Pharmaceuticals to Present at Three Investment Conferences in March
RALEIGH, N.C.Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP) today announced that the Company will present at three health care investment conferences during March 2010. Information on these conferences is provided below: RBC Capital Markets Healthcare...
|
|
|
Salix Pharmaceuticals to Present at Three Investment Conferences in March
BusinessWire - Salix Pharmaceuticals, Ltd.(NASDAQ: SLXP) today announced that the Company will present at three health care investment conferences during March 2010. Information on these conferences is provided below: RBC Capital Markets Healthcare...
|
